![Gillian Hooker](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Gillian Hooker
Directeur Technique/Scientifique/R&D chez Concert Genetics, Inc.
Profil
Gillian Hooker is currently the Chief Scientific Officer at Concert Genetics, Inc. She started this position in 2021.
Prior to her current role, she obtained a doctorate degree from Yale University and a graduate degree from Johns Hopkins Bloomberg School of Public Health.
Postes actifs de Gillian Hooker
Sociétés | Poste | Début |
---|---|---|
Concert Genetics, Inc.
![]() Concert Genetics, Inc. Information Technology ServicesTechnology Services Concert Genetics, Inc. operates as a healthcare IT company that focuses on enhancing the genetic test ordering process for the medical community. Its portfolio includes GeneSource, a tool available for physicians and other healthcare professionals to search for, compare and order genetic tests from various laboratories; and GeneConnect, a utilization management solution that leverages the GeneSource database and provides hospitals and sendout laboratories with the tools to lower costs and address workflow inefficiencies associated with the genetic test ordering process. The company was founded by Mark Harris in 2010 and is headquartered in Franklin, TN. | Directeur Technique/Scientifique/R&D | 01/03/2021 |
Formation de Gillian Hooker
Yale University | Doctorate Degree |
Johns Hopkins Bloomberg School of Public Health | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Concert Genetics, Inc.
![]() Concert Genetics, Inc. Information Technology ServicesTechnology Services Concert Genetics, Inc. operates as a healthcare IT company that focuses on enhancing the genetic test ordering process for the medical community. Its portfolio includes GeneSource, a tool available for physicians and other healthcare professionals to search for, compare and order genetic tests from various laboratories; and GeneConnect, a utilization management solution that leverages the GeneSource database and provides hospitals and sendout laboratories with the tools to lower costs and address workflow inefficiencies associated with the genetic test ordering process. The company was founded by Mark Harris in 2010 and is headquartered in Franklin, TN. | Technology Services |